Global Rheumatology Therapeutics Market 2018-2022

Below are some of the key findings from the rheumatology therapeutics market research report

See the complete table of contents and list of exhibits, as well as selected illustrations and example pages from this report.

Get a FREE sample now!

Global rheumatology therapeutics industry overview

The global rheumatology therapeutics market is expected to grow during the forecast period owing to the increasing prevalence of rheumatic disorders. Rheumatology therapy is proven to have higher efficacy than the other therapies that are currently available in the healthcare industry for the treatment of rheumatoid arthritis. The growth of the global rheumatology therapeutics is expected to be boosted by increased approval of drugs in the development pipeline for the treatment of rheumatic diseases. The rising number of small molecules in the drug development pipeline is one of the major trends being witnessed in the global rheumatology therapeutics. Small molecules are generally less expensive than the biologics and are likely to emerge soon. They will be affordable on a large scale by the patients with juvenile rheumatoid arthritis, axial spondylitis and ankylosing spondylitis, which will drive the market growth. The global rheumatology therapeutics market to grow at a CAGR of over 4% by 2022.

Top rheumatology therapeutics companies covered in this market research report

The rheumatology therapeutics market is fairly fragmented. Most of the established rheumatology therapeutics companies are focused on engaging in strategic alliances to strengthen their market position. Small molecules are generally less expensive than biologics and are likely to emerge in the near future in a strong way. By offering a complete analysis of the market’s competitive landscape and with information on the products offered by the companies, this rheumatology therapeutics industry analysis report will aid clients to identify new growth opportunities and design new growth strategies.

The report offers a complete analysis of various companies including:

• AbbVie
• Amgen
• Janssen Pharmaceuticals
• Pfizer
• UCB

Rheumatology therapeutics market segmentation based on geographic regions

• Americas
• APAC
• EMEA

With a complete study of the growth opportunities for the companies, the Americas region will account for the highest growth of this market throughout the forecast period.

Rheumatology therapeutics market segmentation based on molecule type

• Biologicals
• Small molecules

The biologicals segment will account for the highest market share in global rheumatology therapeutics market. Additionally, the report also provides an accurate prediction of the contribution of the various molecule types segments to the growth of the rheumatology therapeutics market size.

Key highlights of the global rheumatology therapeutics market for the forecast years 2018-2022:

• CAGR of the market during the forecast period 2018-2022
• Detailed information on factors that will accelerate the growth of the rheumatology therapeutics market during the next five years
• Precise estimation of the global rheumatology therapeutics size and its contribution to the parent market
• Accurate predictions on upcoming trends and changes in consumer behavior
• The growth of the rheumatology therapeutics industry across the Americas, APAC and EMEA
• A thorough analysis of the market’s competitive landscape and detailed information on several vendors
• Comprehensive details on the factors that will challenge the growth of rheumatology therapeutics companies

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch